Ghrelin is involved in regulating the progression of Echinococcus Granulosus-infected liver lesions through suppression of immunoinflammation and fibrosis.

Experimental study using murine models and in vitro cell cultures

“In the present study, we observed the changes in serum levels and hepatic protein expression of Ghrelin at different stages of E.g-infected mice, as well as co-localized with different hepatic histiocytes Furthermore, we also intervened with Ghrelin protein and its receptor blocker [D-Lys3]-GHRP-6 in in vitro co-cultures of HepG2 cells and protoscoleces (PSCs) proteins, as well as in in vitro cultures of PSCs alone, and evaluated their regulatory effects on immunoinflammation, fibrotic expression, and growth of PSCs, to further investigate whether Ghrelin has a regulatory role in the progression of hepatic E.g infection.”

6 mice per group for the animal model

“BALB/c mice were randomly divided into 6 groups according to whether they were infected with E.g and the length of rearing: Control group and E.g group (6 mice per group) at 4 weeks, 12 weeks and 36 weeks.”

Mice were observed at 4, 12, and 36 weeks post-infection

“Serum and hepatic Ghrelin levels were observed in E.g-infected mice (4, 12 and 36 weeks) and compared with healthy control groups.”

Serum Ghrelin levels were elevated in early infection stages (4 and 12 weeks) and reduced in late stages (36 weeks).

“Serum Ghrelin levels were increased in E.g-infected 4- and 12-week mice, and reduced in 36-week mice.”

Ghrelin expression co-localized with hepatic stellate cells, T cells, and the TGF-β1/Smad3 pathway in liver lesions.

“E.g-infected mice consistently recruited Ghrelin in and around the hepatic lesions, which was extremely strongly co-localized with the protein expression of hepatic stellate cells (HSCs), T cells and the TGF-β1/Smad3 pathway.”